Polyplus now part of Sartorius’ Post

Sartorius, through its subgroup Sartorius Stedim Biotech, today opened its new Center for Bioprocess Innovation in Marlborough, #Massachusetts. 🎉👏 The facility is designed to foster collaboration, co-development and learning on site with customers and other #innovation partners, applying Sartorius' latest technologies in real-life bioprocess workflows. 💬 "Cell and gene therapies and other novel treatments offer promising solutions for patients with previously incurable diseases. However, these modalities are still in their infancy and often require the development of new manufacturing processes. This cutting-edge innovation center enables us to accelerate and simplify our customers’ path to clinical trials," said René Fáber, CEO of Sartorius Stedim Biotech. Key features include: ➡️ New research labs and process development services to enable next generation therapeutics ➡️Up- and downstream process optimization, proof of concept runs, demos and trainings for customers ➡️Coming 2025: two GMP suites for implementing novel manufacturing processes 🔗 Read media release: https://lnkd.in/emff6U-7 🤝 Massachusetts Executive Office of Economic Development (EOED) | Marlborough Economic Development Corporation | CITY OF MARLBOROUGH | Massachusetts Life Sciences Center | MassBio | Maurice Phelan #SimplifyingProgress #InThisTogether #AdvancedTherapies #CellandGeneTherapy